1 in 3 people will suffer brain illness or injury in their lifetime.
Brain diseases and injuries cost society as much as $2 TRILLION per year in the US and EU.
Brain disorders and injuries cost society more than cancer and cardiovascular disease COMBINED.
1.7 MILLION Americans have Autism.
1.7 MILLION Americans suffer a Traumatic Brain Injury every year.
Approximately 1 million Americans suffer from Parkinson’s disease.
Over 5 million Americans have Alzheimer’s Disease.
For every soldier killed in war in 2012, about 25 veterans took their own lives.
Traumatic Brain Injury (TBI) is one of the LEADING CAUSES OF DEATH AND DISABILITY in America.
By 2023, over 46 million American adults will suffer from a mental disorder.
53,000 Americans die every year due to Traumatic Brain Injury.
8 teenagers die EVERY DAY in the US from TBI.
Neurological disorders constitute 12% of total deaths globally each year.
There are 5 MILLION Americans living with TBI-related disabilities.
Mental disorders make up 35% of the cost of all non-communicable diseases worldwide.
5.3 MILLION Americans have lifelong disabilities due to Traumatic Brain Injury (TBI).
Direct and indirect cost of TBI is $76 BILLION per year in the US.
Nearly 8% of the US population suffers from POST-TRAUMATIC STRESS in their lifetime.
300,000 soldiers suffer TBI and/or PTS.
Women are about twice as likely as men to develop PTSD.
There is 1 military suicide per day in the US.
FOUR people commit suicide EVERY HOUR in the United States.
In the U.S., serious mental illness causes earnings loss of $193.2 billion annually.
90% of suicide victims have a TREATABLE MENTAL DISORDER.
Nearly 10% of people with SCHIZOPHRENIA commit suicide.
Number one sport per capita for traumatic brain injury is GIRLS SOCCER.
HALF A MILLION children under 14 go to the emergency room every year for TBI.
Funding for brain research from government and pharmaceutical companies is DECREASING EVERY YEAR.
Someone develops Alzheimer’s Disease EVERY 68 SECONDS.
Alzheimer’s Disease is the 6th LEADING CAUSE OF DEATH in US adults.
Traumatic brain injury is the leading cause of death and disability in children and young adults.
TBI patients are up to 5 times more likely to develop Alzheimer’s disease.
Medicaid and Medicare spend $130 BILLION per year on Alzheimer’s patients.
One in 10 high school athletes involved in contact sports sustain a concussion each year.
Over 400,000 Americans have Multiple Sclerosis.
An athlete who sustains a concussion is 5 times more likely to sustain a second concussion.
People with TBI are nearly twice as likely to report binge drinking.
The lowest rates of Multiple Sclerosis are in countries nearest to the EQUATOR.
20% of U.S. troops returning from combat tours show symptoms of PTSD or major depression.
DEPRESSION is the LEADING CAUSE of disease burden in the U.S.
Nearly 7% of American adults had a MAJOR DEPRESSIVE EPISODE in the past 12 months.
81.1 million people will be affected by dementia by 2040.
Over 2 MILLION Americans over the age of 18 suffer from BIPOLAR DISORDER.
About one in 10 individuals will have at least one epileptic seizure in their lifetime.
TBI victims are 50% more likely to suffer from depression.
Over 2 MILLION Americans have SCHIZOPHRENIA.
Among people with MS, physical disability contributes to a nearly 70% unemployment rate.
The annual medical cost of Schizophrenia in the US is OVER $32B.

Staff and Board


General Peter Chiarelli, United States Army (Retired)

General Peter Chiarelli, USA (Ret.) was appointed the Chief Executive Officer of One Mind for Research in 2012. He is a retired four-star General with 40 years of experience designing and implementing American defense policy for the U.S. Army and Department of Defense in peace and during combat operations.

As the 32nd Vice Chief of Staff in the Army, Chiarelli was responsible for the day-to-day operations of the Army and its 1.1 million active and reserve soldiers. This included the Army’s research, development and execution of studies followed by the implementation of recommendations related to the Army’s behavioral health programs, specifically its Health Promotion, Risk Reduction and Suicide Prevention Program.

As commander of the Multi-National Corps-Iraq, Chiarelli coordinated the actions of all four military services and was responsible for the day-to-day combat operations of more than 147,000 U.S. and Coalition troops. He was also the Senior Military Assistant to the Secretary of Defense from March 2007 to August 2008. Chiarelli pioneered efforts to restore government, economic stability and essential services during two tours in Iraq; exercised command and control of combat operations; and trained, prepared and mobilized reserve forces for critical response operations. He retired from the Army in 2012 after almost 40 years of service.

As the CEO of One Mind for Research, Chiarelli continues his advocacy for eliminating the stigma associated with Service Members and Veterans seeking and receiving the assistance they need for the treatment of the invisible wounds of war: Post-Traumatic Stress (PTS), and Traumatic Brain Injury (TBI). Co-founded by former Congressman Patrick Kennedy and mental health advocate Garen Staglin, One Mind for Research (currently a division of IMHRO) is an independent, non-profit organization bringing together health care providers, researchers, academics and the health care industry - on a global scale – with the goal to rapidly develop new treatments and cures for all illnesses and disorders of the brain.

Chiarelli holds a Bachelor of Science degree in political science from Seattle University; a Master of Public Administration degree from the Daniel J. Evans School of Public Affairs at the University of Washington; and a Master of Arts degree in national security strategy from Salve Regina University. He is also a graduate of the U.S. Naval Command and Staff College and the National War College.

Stephen Johnson

Stephen works on policy issues and intellectual property strategies that drive One Mind's goals of hastening cures for patients through encouraging and enabling data sharing within and across disciplines, addressing barriers to data sharing on policy and technology levels, creating efficient public private partnerships to leverage public, private and philanthropic resources to advance research and cures, and focusing on incentives to innovation in neuroscience.

Before joining One Mind, Stephen had over 30 years of experience in intellectual property law at Kirkland & Ellis LLP, where he was a founding partner of its New York and San Francisco offices and the former head of its New York and San Francisco intellectual property groups. He began his career at Bird & Bird in London.  Stephen obtained a degree in Natural Sciences (Genetics) from Cambridge University in England, and graduated from law schools in London and Chicago.

Stephen's legal practice focused on domestic and international intellectual property based transactions, including joint ventures, product development, university collaborations, outsourcing, finance, royalty buyouts and securitization, and technology driven corporate transactions. Stephen worked predominantly on transactions in the life science and software industries and worked with senior management of clients on a wide range of legal issues including intellectual property risk management and strategy.

Among other distinctions, Stephen was listed in Chambers USA: Leading Lawyers for Business; named as one of America's Top 25 pre-eminent Information Technology practitioners in the publication Guide to the World's Leading Lawyers - Best of the Best USA, 2011; and included in Intellectual Asset Management magazine's list of the world's top patent and technology licensing lawyers. He is a former chair of the Technology Committee of the International Bar Association.

Janet Carbary, CPA

Janet Carbary is the Chief Financial Officer of One Mind. She has a diverse background organizational management and stragetic planning in the healthcare industry. Janet has held executive positions in finance and management, with over 25 years of experience as CFO, COO, and CEO with hospital systems in Texas, New Mexico, and Washington State. She has done additional work for a clinical laboratory and a start-up durable medical company.

Janet earned her Bachelor of Arts in Accounting from Eastern Washington University and did postgraduate work in the MBA program at Gonzaga University.

Lenny O'Donnell

Lenny is the Chief Marketing and Communications Officer for One Mind. His career in media, marketing, and communications has been primarily focused on production of film and television content, along with advertising and marketing campaigns on screen, on line, and in print.

An award-winning producer, Lenny has dozens of credits in major network television, including programming for NBC, Paramount, MGM, Bravo, Showtime, Discovery, Travel Channel, and MSNBC.

He has also produced several notable feature films, including the 2006 Academy Award Best Documentary semifinalist On Native Soil, narrated by Oscar winners Kevin Costner & Hilary Swank.  The film has been lauded as one of the most important films made about the terrorist attacks of September 11, 2001.

Prior to joining One Mind, he was the Director and co-founder of the Masters Degree program in Producing for Film & Digital Media at the Seattle Film Institute, where he taught postgraduate courses in business, marketing, public relations, and finance.

Lenny is a graduate of Queen Anne High School and the University of Washington in Seattle.

Joan Demetriades, MBA

Joan Demetriades is the Chief Strategy Officer of One Mind.  She brings extensive experience in pharmaceutical R&D strategy development, strategic leadership, portfoli planning, program & project management, organizational effectiveness, merger integration, bioanalytical chemistry and pharmacokinetics.

Joan’s career spans executive and leadership positions at Janssen Pharmaceuticals R&D, Johnson & Johnson Pharmaceutical R&D, AstraZeneca, Astra Merck, and Merck Research Labs.

Joan received a Masters of Business Administration from La Salle University and a Bachelor of Science in Medical Technology from Duquesne University.



Garen K. Staglin

Garen is the co-founder and co-chairman of One Mind for Research, and the co-founder, President, and trustee of the International Mental Health Research Organization. During the past 18 years, IMHRO and the Staglin’s Music Festival for Mental Health event have raised more than $140 million for mental health charities and research. He is also co-founder and President of Bring Change 2 Mind, a non-profit organization dedicated to eliminating the stigma of mental illness.

Garen has spent more than 30 years building and starting companies in the financial services and payment industries as a private equity investor and philanthropist. He currently serves on the Board of Directors of Silicon Valley Bank, ExL Services, NVoice Payments, Profit Velocity Solutions, and Specialized Bicycle Corporation. He is also a Senior Advisor to FTV Capital.

He earned his Bachelor of Science in Engineering from UCLA and his MBA from the Stanford Graduate School of Business. He is a recipient of the Gold Spike Award, Stanford University’s highest award for volunteer service and the UCLA College of Letters & Science Fellows Award.

Garen, his wife Shari, and their children, Brandon and Shannon, are founders of the Staglin Family Vineyard in Rutherford, California. Actively involved for 25 years in the wine industry, the Staglins’ motto is “Great Wine for Great Causes” and through the operation of their winery, business interests, and support of various charitable causes, they have indeed lived up to that philosophy. In the last ten years, causes they have chaired or donations from their wines have generated more than $750 million.

Patrick J. Kennedy

Patrick Kennedy, the co-founder of One Mind for Research, served 16 years in the U.S. House of Representatives and is predominantly known as the author and lead sponsor of the Mental Health Parity & Addiction Equity Act of 2008. This dramatic piece of legislation provides access to mental health treatment to tens of millions of Americans who previously were denied care.

Congressman Kennedy has authored and co-sponsored dozens of bills to increase the understanding and treatment of neurological and psychiatric disorders, including the National Neurotechnology Initiative Act, the Genomics and Personalized Medicine Act, the COMBAT PTSD Act, and the Alzheimer’s Treatment and Caregiver Support Act.

He is a winner of the American College of Neuropsychopharmacology Distinguished Service Award, the Society for Neuroscience Public Service Award, the Autism Society of America Congressional Leadership Award, the Depression and Bipolar Support Paul Wellstone Mental Health Award, and the Epilepsy Foundation Public Service Award. He is also founder of the Congressional Down Syndrome Caucus and the 21st Century Healthcare Caucus.

Shumeet Banerji

Shumeet Banerji is a Senior Partner of Booz & Company. He was the founding Chief Executive Officer of Booz & Company from 2008-2012. He joined the firm in Chicago in 1993. Prior to his election to CEO, he was the Managing Director of the firm’s European practice. He co-founded and co-led the firm’s practice in India in the mid-1990s. Mr. Banerji has advised public and private sector entities around the world, serving clients in the financial services, telecoms, technology and media, consumer products and retail, resources, steel, and chemicals industries. He has advised diversified conglomerates, investors, and governments. Typical issues have spanned the entire senior agenda, including corporate strategy, senior organization, board performance, transformational change, operational performance improvement, M&A, and compensation.

He is a frequent speaker at key economic and business conferences around the world including the World Economic Forum and the Global Economic Symposium. For the last few years he has focused on leadership issues in the aftermath of the financial crisis. He is the author of numerous articles and is co-author of Cut Costs and Grow Stronger.

Mr. Banerji serves on the Board of Directors of Hewlett-Packard Company, the Panel of Senior Advisers of Chatham House (The Royal Institute of International Affairs) and the Dean’s Advisory Board of the Kellogg School of Management, Northwestern University, where he received his Ph.D. He was a member of the faculty at the University of Chicago's Graduate School of Business before joining the firm.

Matthias Bowman

Mr. Bowman founded RCT Logic, LLC in 2008. Previously, he was Vice Chairman of Investment Banking at Merrill Lynch and Chief Executive Officer of Merrill Lynch Ventures.

Mr. Bowman is a founder of Fieldpoint Private Bank & Trust, and has previously served on the Board of Directors of MedAvante, Definity Health, Active Health Management, Borg-Warner Automotive, Del Monte Foods, Supermarkets General Corporation, Teleport Communications Group, and U.S. Foodservice.

Mr. Bowman manages the Bowman Family Foundation. He is also a member of the Board of Directors of the International Mental Health Research Organization (IMHRO) and the Sylvan C. Herman Foundation, and is a member of two Advisory Committees of Massachusetts General Hospital and the Board of Advisors of ACTTION (a public private partnership founded by the FDA which is focused on improving development of analgesic therapies). He was formerly a Trustee, member of the Executive Committee, and Chairman of the Finance Committee of the American Cancer Society Foundation, and a member of the Board of Directors and the Executive Committee of NARSAD.

Mr. Bowman attended Williams College, where he was elected Phi Beta Kappa in 1969 and graduated summa cum laude in 1970. In 1972 he graduated from the Harvard Business School as a Baker Scholar. In recent years he has studied Molecular Biology, Neuroscience and Biostatistics.

Gary Gottlieb, MD

Gary Gottlieb is the president and CEO of Partners HealthCare. At Partners, he previously served as president of Brigham and Women’s/Faulkner Hospitals, as the president of North Shore Medical Center and as Chairman of Partners Psychiatry and Mental Health System. He is a professor of psychiatry at Harvard Medical School.

Prior to joining Partners HealthCare, Gary spent 15 years in positions of increasing leadership in health care. He attended the University of Pennsylvania as a Robert Wood Johnson Foundation Clinical Scholar. Through that program, he earned a Master of Business Administration with Distinction in Health Care Administration from Penn’s Wharton Graduate School of Business Administration. Gary went on to establish Penn Medical Center’s first program in geriatric psychiatry and developed it into a nationally recognized research, training and clinical program. He rose to become Executive Vice-Chair and Interim Chair of Penn’s Department of Psychiatry and the Health System’s Associate Dean for Managed Care. Later, Gary became the Director and Chief Executive Officer of Friends Hospital in Philadelphia, the nation’s oldest freestanding psychiatric hospital.

In addition to his noteworthy academic, clinical and management record, Gary has published extensively in geriatric psychiatry and health care policy. He is a past President of the American Association of Geriatric Psychiatry.

Gary received his Bachelor of Science cum laude from the Rensselaer Polytechnic Institute and his Doctor of Medicine from the Albany Medical College of Union University. He completed his internship and residency and served as Chief Resident in Psychiatry at New York University/Bellevue Medical Center.

As a recognized community leader in Boston, Gary focuses his attention on workforce development and disparities in health care. He was appointed by Mayor Thomas Menino as Chairman of the Private Industry Council, the City’s workforce development board, which partners with education, labor, higher education, the community and government, to provide oversight and leadership to public and private workforce development programs, and he served as co-chair of the Mayor’s Task Force to Eliminate Health Disparities. He also serves on the boards of Partners In Health and the Federal Reserve Bank of Boston. He is a member of the Institute of Medicine of the National Academies of Sciences.